4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)
- Status
- COMPLETED
- Phase
- PHASE3
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE4
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE3
The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）
- Status
- UNKNOWN
- Phase
- PHASE3
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN
- Status
- COMPLETED
- Phase
- PHASE2
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Biweekly Docetaxel in Patients With Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2